Severe Herpesvirus Infections in an Adolescent without Natural Killer Cells

New England Journal of Medicine

Volumn 320, Issue 26, 1989, Pages 1731-1735

  Biron, Christine A ^b   Byron, Kevin S ^a   Sullivan, John L ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; CASE REPORT; FEMALE; HERPES VIRUS INFECTION; HUMAN; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL;

EID: 0024315206     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198906293202605     Document Type: Article

References (24)

1. Timonen T, Ranki A, Saksela E, Hayry P. Human natural cell-mediated cytotoxicity against fetal fibroblasts. III. Morphological and functional characterization of the effector cells. Cell Immunol 1979; 48: 121–32.
2. Lanier LL, Le AM, Phillips JH, Warner NL, Babcock GF. Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens. J Immunol 1983; 131: 1789–96.
3. Krensky AM, Sanchez-Madrid F, Robbins E, Nagy JA, Springer TA, Burakoff SJ. The functional significance, distribution, and structure of LFA-1, LFA-2, and LFA-3: cell surface antigens associated with CTL-target interactions. J Immunol 1983; 131: 611–6.
4. Hercend T, Griffin JD, Bensussan A, et al. Generation of monoclonal antibodies to a human natural killer clone: characterization of two natural killer-associated antigens, NKH1A and NKH2, expressed on subsets of large granular lymphocytes. J Clin Invest 1985; 75: 932–43.
5. Trinchieri G, Santoli D. Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells: enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis. J Exp Med 1978; 147: 1314–33.
6. Trinchieri G, Matsumoto-Kobayashi M, Clark SC, Seehra J, London L, Perussia B. Response of resting human peripheral blood natural killer cells to interleukin 2. J Exp Med 1984; 160: 1147–69.
7. Welsh RM Jr, Hallenbeck LA. Effect of virus infections on target cell susceptibility to natural killer cell-mediated lysis. J Immunol 1980; 124: 2491–7.
8. Habu S, Akamatsu K, Tamaoki N, Okumura K. In vivo significance of NK cell on resistance against viras (HSV-1) infections in mice. J Immunol 1984; 133: 2743–7.
9. Bancroft GJ, Shellam GR, Chalmer JE. Genetic influences on the augmentation of natural killer (NK) cells during murine cytomegalovirus infection: correlation with patterns of resistance. J Immunol 1981; 126: 988–94.
10. Bukowski JF, Woda BA, Habu S, Okumura K, Welsh RM. Natural killer cell depletion enhances virus synthesis and virus-induced hepatitis in vivo. J Immunol 1983; 131: 1531–8.
11. Bukowski JF, Warner JF, Dennert G, Welsh RM. Adoptive transfer studies demonstrating the antiviral effect of natural killer cells in vivo. J Exp Med 1985; 161: 40–52.
12. Quinnan GV Jr, Kirmani N, Rook AH, et al. Cytotoxic T cells in cytomegalovirus infection: HLA-restricted T-lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone-marrow-transplant recipients. N Engl J Med 1982; 307: 7–13.
13. Padgett GA, Reiquam CW, Henson JB, Gorham JR. Comparative studies of susceptibility to infection in the Chediak-Higashi syndrome. J Pathol Bacteriol 1968; 95: 509–22.
14. Anderson DC, Schmalsteig FC, Finegold MJ, et al. The severe and moderate phenotypes of heritable Mac-1, LFA-1 deficiency: their quantitative definition and relation to leukocyte dysfunction and clinical features. J Infect Dis 1985; 152: 668–89.
15. Tomkinson BE, Wagner DK, Nelson DL, Sullivan JL. Activated lymphocytes during acute Epstein–Barr virus infection. J Immunol 1987; 139: 3802–7.
16. Biron CA, Natuk RJ, Welsh RM. Generation of large granular T lymphocytes in vivo during viral infection. J Immunol 1986; 136: 2280–6.
17. Sullivan JL, Byron KS, Brewster FE, Purtilo DT. Deficient natural killer cell activity in X-linked lymphoproliferative syndrome. Science 1980; 210: 543–5.
18. Grimm E, Bonavida B. Mechanism of cell-mediated cytotoxicity at the single cell level. I. Estimation of cytotoxic T lymphocyte frequency and relative lytic efficiency. J Immunol 1979; 123: 2861–9.
19. Biron CA, Welsh RM. Blastogenesis of natural killer cells during viral infection in vivo. J Immunol 1982; 129: 2788–95.
20. London L, Perussia B, Trinchieri G. Induction of proliferation in vitro of resting human natural killer cells: expression of surface activation antigens. J Immunol 1985; 134: 718–27.
21. Griffin JD, Ritz J, Nadler LM, Schlossman SF. Expression of myeloid differentiation antigens on normal and malignant myeloid cells. J Clin Invest 1981; 68: 932–41.
22. Chilmonczyk BA, Levin MJ, McDuffy R, Hayward AR. Characterization of the human newborn response to herpesvirus antigen. J Immunol 1985; 134: 4184–8.
23. Bukowski JF, Welsh RM. Inability of interferon to protect virus–infected cells against lysis by natural killer (NK) cells correlates with NK cell-mediated antiviral effects in vivo. J Immunol 1985; 135: 3537–41.
24. Phillips JH, Lanier LL. Dissection of the lymphokine-activated killer phenomenon: relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis. J Exp Med 1986; 164: 814–25.